Hospital
Mount Carmel Health System
Mount Carmel Health System was paid $14.42M by Medicaid between Jan 2018 and Jun 2020, across 161 billing codes. Its largest line is 99283, emergency room visit (moderate) — 24% of everything it billed.
33Billing provider infoMOUNT CARMEL HEALTH SYSTEM
GROVE CITY, OH 43123
GROVE CITY, OH 43123
33aNPI1710067376assigned 10/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$14.42M
24GClaims434,447
24DCodes billed161
24AFirst – last monthJan 2018 – Jun 2020
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#63 of 101
Median peer was paid$22.32M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 271,837 | $8.63M | |
| 2019 | 152,794 | $5.25M | |
| 2020 | 9,816 | $535K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 37,112 | 35,336 | $3.49M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 30,169 | 28,343 | $3.15M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.8% | 12,422 | 11,441 | $1.42M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 9.4% | 17,109 | 14,351 | $1.35M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.4% | 13,034 | 12,608 | $1.06M |
| 96361 | Intravenous infusion, hydration; each additional hour | 7.1% | 6,438 | 5,779 | $1.02M |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.5% | 38,128 | 34,172 | $642K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.6% | 3,664 | 3,561 | $379K |
| 59025 | Fetal non-stress test | 1.4% | 2,173 | 987 | $199K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.3% | 3,385 | 2,903 | $182K |
| G0378 | Hospital observation service, per hour | 1.1% | 2,941 | 1,263 | $155K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 655 | 616 | $115K |
149 more codes
| 84484 | <1% | 6,743 | $110K | |
| 80053 | Comprehensive metabolic panel | <1% | 6,516 | $93K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,327 | $60K |
| 80061 | Lipid panel | <1% | 4,695 | $52K |
| 80076 | <1% | 5,329 | $49K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,621 | $44K |
| 36415 | Collection of venous blood by venipuncture | <1% | 56,201 | $38K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,797 | $38K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 458 | $36K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,077 | $35K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 37,106 | $35K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 224 | $33K |
| 62323 | <1% | 133 | $33K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 151 | $33K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,171 | $32K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,369 | $31K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 827 | $31K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 344 | $31K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 467 | $25K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 362 | $23K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,047 | $22K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 158 | $22K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,633 | $19K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 14,951 | $19K |
| 82607 | <1% | 1,053 | $16K | |
| 87536 | <1% | 313 | $15K | |
| 76820 | <1% | 562 | $14K | |
| 84146 | <1% | 469 | $14K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 733 | $13K |
| 86780 | <1% | 691 | $13K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,344 | $12K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 54 | $12K |
| 64493 | <1% | 27 | $11K | |
| 76801 | <1% | 213 | $10K | |
| 86360 | <1% | 292 | $10K | |
| 85027 | <1% | 2,640 | $9K | |
| 84439 | <1% | 918 | $9K | |
| 81001 | <1% | 18,832 | $8K | |
| 86140 | <1% | 604 | $7K | |
| 80050 | General health panel | <1% | 510 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 15,884 | $7K |
| 86701 | <1% | 582 | $7K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 37 | $7K |
| 82746 | <1% | 364 | $5K | |
| 90715 | <1% | 259 | $5K | |
| 80320 | <1% | 242 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 227 | $5K |
| 82728 | <1% | 430 | $4K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 226 | $4K |
| 81025 | <1% | 14,356 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 123 | $3K |
| 86480 | <1% | 51 | $3K | |
| 83735 | <1% | 749 | $3K | |
| 83540 | <1% | 502 | $3K | |
| 74280 | <1% | 27 | $3K | |
| 76818 | <1% | 60 | $2K | |
| 82043 | <1% | 575 | $2K | |
| 86762 | <1% | 210 | $2K | |
| 87340 | <1% | 231 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 26 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 9,751 | $2K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 48 | $2K |
| 82947 | <1% | 309 | $2K | |
| 20610 | <1% | 15 | $2K | |
| 86803 | <1% | 207 | $2K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 23 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 18 | $2K |
| 86787 | <1% | 158 | $2K | |
| 86900 | <1% | 181 | $2K | |
| 87040 | <1% | 78 | $1K | |
| 86850 | <1% | 193 | $1K | |
| 83605 | <1% | 63 | $1K | |
| 59430 | <1% | 15 | $1K | |
| 83013 | <1% | 35 | $1K | |
| 73130 | <1% | 127 | $1K | |
| 86901 | <1% | 184 | $967.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 54 | $964.46 |
| 84207 | <1% | 66 | $956.55 | |
| 83721 | <1% | 76 | $852.73 | |
| 83690 | <1% | 3,223 | $836.46 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 112 | $785.82 |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 29 | $781.70 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,207 | $777.10 |
| 84425 | <1% | 60 | $761.24 | |
| 86735 | <1% | 52 | $751.79 | |
| 73630 | <1% | 94 | $613.92 | |
| 73110 | <1% | 94 | $584.89 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,386 | $575.56 |
| 86765 | <1% | 53 | $548.83 | |
| 85652 | <1% | 155 | $548.21 | |
| 83970 | <1% | 39 | $544.71 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 13 | $511.28 |
| 86706 | <1% | 49 | $509.87 | |
| 87210 | <1% | 503 | $506.21 | |
| 82248 | <1% | 122 | $423.19 | |
| 86200 | <1% | 28 | $412.83 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 257 | $357.41 |
| 81003 | <1% | 1,416 | $347.19 | |
| 00731 | <1% | 110 | $346.63 | |
| 86141 | <1% | 16 | $342.02 | |
| 86431 | <1% | 26 | $316.49 | |
| 84153 | <1% | 24 | $307.94 | |
| 80329 | <1% | 25 | $298.38 | |
| 86696 | <1% | 18 | $279.62 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 807 | $277.16 |
| 86038 | <1% | 25 | $267.93 | |
| 85379 | <1% | 13 | $255.52 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,063 | $242.76 |
| 90658 | <1% | 28 | $230.06 | |
| 73610 | <1% | 381 | $216.01 | |
| 84703 | <1% | 26 | $204.72 | |
| 84550 | <1% | 98 | $204.10 | |
| 86695 | <1% | 18 | $196.39 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,512 | $173.44 |
| 87186 | <1% | 52 | $167.22 | |
| 84460 | <1% | 40 | $146.38 | |
| 87081 | <1% | 13 | $135.59 | |
| J2704 | Injection, propofol, 10 mg | <1% | 348 | $132.68 |
| 73560 | <1% | 324 | $107.49 | |
| 82565 | <1% | 62 | $103.11 | |
| 84520 | <1% | 48 | $91.86 | |
| 80051 | <1% | 36 | $82.15 | |
| 83880 | <1% | 16 | $75.82 | |
| 71045 | Radiologic examination, chest; single view | <1% | 114 | $54.00 |
| 85610 | <1% | 42 | $53.16 | |
| 85007 | <1% | 29 | $32.90 | |
| 83550 | <1% | 19 | $29.52 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,683 | $29.37 |
| 84100 | <1% | 14 | $21.36 | |
| 81002 | <1% | 15 | $18.10 | |
| 87205 | <1% | 14 | $16.81 | |
| 84156 | <1% | 12 | $15.44 | |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 189 | $13.47 |
| 87070 | <1% | 14 | $8.41 | |
| 87176 | <1% | 14 | $8.41 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 76 | $5.20 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,259 | $2.28 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 30 | $2.28 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 30 | $1.90 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $1.16 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 25 | $0.00 |
| 96376 | 0% | 176 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 12 | $0.00 |
| 90657 | 0% | 65 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 23 | $0.00 |
| 64494 | 0% | 14 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 247 | $0.00 |
| H1000 | Prenatal care, at-risk assessment | 0% | 332 | $0.00 |
| 73030 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRIDAY, ANDREW (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Mount Carmel Health System | Columbus, OH | $66.65M |
| Mount Carmel Health System | Westerville, OH | $42.48M |
| Diley Ridge Medical Center | Canal Winchester, OH | $6.17M |
| Mount Carmel Health System | Columbus, OH | $5.23M |
| Mount Carmel Health System | Columbus, OH | $403K |
| Mount Carmel Health System | Columbus, OH | $318K |
| Mount Carmel Health System | Grove City, OH | $180K |
| Mount Carmel Health System | New Albany, OH | $14K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.